Abstract
Thank you for allowing me to comment on the letter by Frankel. The other authors and I are unaware that clinicians have used our report to suggest that postoperative irradiation might not be appropriate in high-grade soft-tissue sarcoma of the extremities in adults. In fact, our group has demonstrated in a prospective randomized study that there is a value in adjuvant brachytherapy in limiting local recurrence of soft-tissue sarcoma.1 What our present report describes is our experience in terms of local and systemic recurrence in patients with small (smaller than 5 cm) primary (ie, not previously treated) soft-tissue sarcoma of the extremity. Historically, such patients with high-grade lesions (smaller than 5 cm) would be included in the American Joint Committee on Cancer stage III group. The implication is that survival in this patient group would be approximately 30% at 5 years. What the present article demonstrates is
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
